FDA Inspection
InvaGen Pharmaceuticals, Inc.FDA Inspection 1053263 - InvaGen Pharmaceuticals, Inc. - May 25, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns InvaGen Pharmaceuticals, Inc., with an inspection on May 25, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · e3d4a9c8-e980-4a32-9fdf-d26c6a11a868
Violation Codes6
21 CFR 211.160(b)21 CFR 211.166(a)21 CFR 211.19221 CFR 211.68(b)21 CFR 314.81(b)(1)(i)21 CFR 314.81(b)(1)(ii)
Full citation text and observation details available on the Dashboard.